Monte Rosa Therapeutics, Inc. GLUE · SEC Filings

website

173

Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-mo...

Price10.58

Market Cap902.62 M

Float60.17 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Monte Rosa Therapeutics Reports Third Quarter 2026 Financial Results and Provides Pipeline Updates

Nov 5, 2026

8-K

Phase 1 data show MRT-8102 normalized ASCVD biomarkers, robustly degraded NEK7, and demonstrated favorable safety across tested doses

Oct 1, 2026

8-K

Monte Rosa Therapeutics Announces Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391) in Sjögren’s Disease by Novar

Sep 8, 2026

8-K

Monte Rosa Therapeutics Reports Second Quarter 2026 Financial Results and Clinical Pipeline Progress

Aug 6, 2026

8-K

Monte Rosa Therapeutics, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 11, 2026

8-K

Monte Rosa Therapeutics Reports Q1 2026 Financial Results and Pipeline Progress

May 7, 2026

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 18, 2026

S-3ASR

February 2026 SHELF + ATM

Feb 11, 2026

S-3

Mar 20, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 20, 2025

S-8

Registration

Mar 14, 2024

S-8

Registration

Mar 16, 2023

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 25, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 25, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 26, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 26, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT